{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:06:54Z","timestamp":1760299614625,"version":"3.38.0"},"reference-count":26,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.nephro.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T14:31:26Z","timestamp":1497018686000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Qualit\u00e9 de vie des patients atteints de polykystose r\u00e9nale autosomique dominante"],"prefix":"10.1684","volume":"13","author":[{"given":"Laurent","family":"Lecardeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2016.12.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","author":"Willey","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.12.005_bib0140","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2016.12.005_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"year":"1993","series-title":"WHOQOL study protocol","author":"World Health Organization","key":"10.1016\/j.nephro.2016.12.005_bib0150"},{"key":"10.1016\/j.nephro.2016.12.005_bib0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.encep.2015.07.001","article-title":"La qualit\u00e9 de vie en schizophr\u00e9nie","volume":"41","author":"Lecardeur","year":"2015","journal-title":"Enc\u00e9phale"},{"year":"2012","series-title":"Guide du parcours de soins. Maladie r\u00e9nale chronique de l\u2019adulte","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","key":"10.1016\/j.nephro.2016.12.005_bib0160"},{"year":"2014","series-title":"Actes et prestations\u00a0\u2013\u00a0ALD no\u00a019. N\u00e9phropathie chronique grave","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","key":"10.1016\/j.nephro.2016.12.005_bib0165"},{"year":"2015","series-title":"La d\u00e9claration de Bruxelles sur la PKRAD","author":"European ADPKD Forum","key":"10.1016\/j.nephro.2016.12.005_bib0170"},{"key":"10.1016\/j.nephro.2016.12.005_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2215\/CJN.02410508","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis","volume":"4","author":"Rizk","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2016.12.005_bib0180","first-page":"120","article-title":"Anxiety, depression, and quality of life in patients with familial glomerulonephritis or autosomal dominant polycystic kidney disease","volume":"33","author":"de Barros","year":"2011","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.nephro.2016.12.005_bib0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2369-14-179","article-title":"Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study","volume":"14","author":"Suwabe","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2016.12.005_bib0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1\u20134: a cross-sectional study","volume":"63","author":"Miskulin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2016.12.005_bib0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.ajkd.2013.07.016","article-title":"Bilateral nephrectomy significantly improves health-related quality of life in a hemodialysis patient with autosomal dominant polycystic kidney disease","volume":"62","author":"Chao","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2016.12.005_bib0200","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ndt\/gfv299","article-title":"Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease","volume":"31","author":"Simms","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.12.005_bib0205","doi-asserted-by":"crossref","first-page":"A183","DOI":"10.1016\/j.jval.2013.03.921","article-title":"Psychometric analyses of patients-reported outcome instruments for autosomal dominant polycystic kidney disease","volume":"16","author":"Cole","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.nephro.2016.12.005_bib0210","doi-asserted-by":"crossref","first-page":"A512","DOI":"10.1016\/j.jval.2015.09.1479","article-title":"Health-related quality of life (Hrqol) measures in autosomal dominant polycystic kidney disease (Adpkd)","volume":"18","author":"Oberdhan","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.nephro.2016.12.005_bib0215","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfw335","article-title":"Health-related quality of life across all stages of autosomal dominant polycystic kidney disease","author":"Eriksson","year":"2016","journal-title":"Nephrol Dial Transplant"},{"year":"1997","series-title":"Kidney Disease Quality of Life Short Form (KDQOL-SF\u2122), version 1.3: a manual for use and scoring","author":"Hays","key":"10.1016\/j.nephro.2016.12.005_bib0220"},{"key":"10.1016\/j.nephro.2016.12.005_bib0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ckj\/sfv060","article-title":"Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians","volume":"8","author":"Baker","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2016.12.005_bib0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ndt\/gfv010","article-title":"A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research","volume":"30","author":"Tong","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 4","key":"10.1016\/j.nephro.2016.12.005_bib0235","doi-asserted-by":"crossref","first-page":"iv142","DOI":"10.1093\/ndt\/gfu073","article-title":"A stepwise approach for effective management of chronic pain in autosomal dominant polycystic kidney disease","volume":"29","author":"Casteleijn","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.12.005_bib0240","doi-asserted-by":"crossref","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","article-title":"Clinical correlates of mass effect in autosomal dominant polycystic kidney disease","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nephro.2016.12.005_bib0245","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pmn.2009.03.002","article-title":"\u201cAn evil heritage\u201d: interview study of pain and autosomal dominant polycystic kidney disease","volume":"10","author":"Heiwe","year":"2009","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.nephro.2016.12.005_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.33590\/emjnephrol\/10311476","article-title":"Pain in autosomal dominant polycystic kidney disease","volume":"1","author":"Niemczyk","year":"2014","journal-title":"EMJ Neph"},{"key":"10.1016\/j.nephro.2016.12.005_bib0255","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.socscimed.2010.06.040","article-title":"Voicing the lifeworld: parental accounts of responsibility in genetic consultations for polycystic kidney disease","volume":"72","author":"Clarke","year":"2011","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.nephro.2016.12.005_bib0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ndt\/gfv058","article-title":"More than a kidney disease: a patient-centred approach to improving care in autosomal dominant polycystic kidney disease","volume":"30","author":"Youssouf","year":"2015","journal-title":"Nephrol Dial Transplant"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517301608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517301608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2016.12.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:42:39Z","timestamp":1741192959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517301608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1769725517301608"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2016.12.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualit\u00e9 de vie des patients atteints de polykystose r\u00e9nale autosomique dominante","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}